SCHEMBL6489152

SCHEMBL6489152

[CH2]n1c(C(C)(C)C)nc2ncccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.39
KMT2A Q03164 3/20 0.38
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
HTR3E A5X5Y0 1/20 0.36
HTR3B O95264 1/20 0.36
HTR3A P46098 1/20 0.36
HTR3D Q70Z44 1/20 0.36
HTR3C Q8WXA8 1/20 0.36
PDE2A O00408 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HRH4 Q9H3N8 1/20 0.33
RPS6KA5 O75582 1/20 0.33
RPS6KA4 O75676 1/20 0.33
CYP1A2 P05177 2/20 0.31
SLC22A12 Q96S37 2/20 0.31
CYP2C9 P11712 1/20 0.31
ADORA3 P0DMS8 1/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6489159 0.81 HTR3E (0.40) BACE1KMT2ANPC1RAB9AHTR3E
SCHEMBL14336554 0.78 S1PR1 (0.41) BACE1KMT2ANPC1RAB9AHTR3E
SCHEMBL6492951 0.77 BACE1 (0.45) BACE1KMT2ANPC1RAB9AHTR3E
SCHEMBL15746018 0.76 BACE1 (0.42) BACE1KMT2ANPC1RAB9AHTR3E
SCHEMBL10041264 0.74 BACE1 (0.35) BACE1KMT2ANPC1RAB9AHTR3E
SCHEMBL14504058 0.74 CNR2 (0.39) BACE1KMT2ANPC1RAB9AHTR3E
SCHEMBL6479694 0.73 CNR2 (0.46) L3MBTL1KDM4EATM
SCHEMBL6491448 0.72 BACE1 (0.39) BACE1KMT2ANPC1RAB9AHTR3E
SCHEMBL6487932 0.72 S1PR1 (0.39) BACE1KMT2ANPC1RAB9AHTR3E
SCHEMBL14124487 0.72 IDO1 (0.41) BACE1KMT2ANPC1RAB9AHTR3E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6962938-B2 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE) BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2005-11-08 US disclosed
US-6720329-B2 ANTIINFLAMMATORY AGENTS BRISTOL-MYERS SQUIBB PHARMA 2004-04-13 US disclosed
EP-1373199-A4 SPIRO-CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF-ALPHA CONVERTING ENZYME (TAGE) BRISTOL MYERS SQUIBB PHARMA CO (US) 2004-04-07 EP disclosed
EP-1373199-A2 SPIRO-CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF-ALPHA CONVERTING ENZYME (TAGE) Bristol-Myers Squibb Pharma Company (US) 2004-01-02 EP disclosed
WO-2002074738-A2 SPIRO-CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND TNF-ALPHA CONVERTING ENZYME (TAGE) BRISTOL-MYERS SQUIBB COMPANY (US) 2002-09-26 WO disclosed